Figure 6From: Dipyridamole augments the antiinflammatory response during human endotoxemiaBox-and-whiskers (whiskers, range) of the endotoxemia-induced changes in FRAP. FRAP increases during endotoxemia, in both dipyridamole- and placebo-treated subjects (P = 0.08 and 0.02, respectively). No differences between groups were found, as analyzed with two-way ANOVA (P = 036).Back to article page